CHICAGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Zarminali Health, the first outpatient pediatric destination purpose-built to provide modern, seamlessly coordinated primary and specialty care nationwide, today announced $40M in seed financing led by General Catalyst. The company will leverage the latest healthcare technology and an integrated approach to both primary and specialty care that alleviates family burdens and revitalizes patient and clinician experiences. This substantial... Read more
Adjusted EBITDA increases 23% YoY FXN, maintaining strong growth
Leverage ratio decreases 0.4x to 3.7x LUXEMBOURG / Nov 19, 2024 / Business Wire / Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru and Colombia, today announced unaudited financial results for the third quarter ended September 30, 2024 (“third quarter 2024” or “3Q24”). Financial results are expressed in Peruvian... Read more
WOONSOCKET, R.I., Nov. 19, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Dr. Sreekanth Chaguturu will be President, Health Care Delivery, in addition to his current role as Executive Vice President and Chief Medical Officer of CVS Health. Dr. Chaguturu replaces Mike Pykosz, who has decided to leave the company.
"Sree and I worked closely together when he started at CVS Health, serving as chief medical officer of CVS Caremark. In that role,... Read more
Strategic Relationship: Agreement expands access to ECMO solutions for hospitals, health systems and patients in the U.S. nationwide.
Wide Reach: 4,350+ Premier member hospitals and health systems in the U.S. can leverage pre-negotiated terms and pricing on the Novalung System for ECMO.
Commitment to Quality Care: Reinforces company's commitment to supporting healthcare providers in their efforts to deliver high-quality critical care treatments and soluti... Read more
LONG BEACH, Calif. / Nov 18, 2024 / Business Wire / Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced the closing of its previously announced offering of $750 million aggregate principal amount of 6.250% senior notes due 2033 (the “Notes”) sold in a private offering to individuals reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to certain... Read more
NUTEX HEALTH CONTINUES TO EXPAND ITS NATIONAL FOOTPRINT WITH ITS THIRD HOSPITAL OPENING IN 2024 HOUSTON, Nov. 18, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 23 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in ten states and primary care-centric, risk-bearing physician networks, today announced the opening of Milwaukee ER &... Read more
CVS Health Board of Directors appoints four new members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman
Appointments follow productive engagement with Glenview Capital Management WOONSOCKET, R.I., Nov. 18, 2024 /PRNewswire/ -- The Board of Directors of CVS Health (NYSE: CVS) today announced the appointment of four new board members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman, following productive discussions with Glenview Capital M... Read more
MONTRÉAL, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a leading Canadian health tech company, announces that it successfully deployed AI at its two subsidiaries to meet its digital transformation, efficiency and sustainability objectives.
Premier Health has deployed AI capabilities at its two Quebec per diem subsidiaries, Premier Soin and Code Bleu. The AI’s maturity has achieved a remarkable... Read more
Third quarter total revenue of $17.6 million, up 9% year-over-year
Adjusted EBITDA(1) of $0.7 million, up 9% year-over-year, and our 23rd consecutive quarter of positive adjusted EBITDA
Positive cash flow, with net debt down 8% versus September 30, 2023, and with significant investments in our facilities to support future growth TORONTO / Nov 14, 2024 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network... Read more
CERRITOS, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three and nine months ended September 30, 2024.
Recent Operational Highlights Include 79.9% increase in Dispensary segment revenue compared to prior year quarter
Welcomed Rob Carter, as our new Chief Financial Officer
3... Read more
SAN JUAN CAPISTRANO, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the EnsignTM group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it will participate in the Stephens Annual Investment Conference on November 20, 2024.
Barry Port, Chief... Read more
Revenue increases 36.3% period over period
Conference Call on November 13th at 1:00 pm ET SAN FRANCISCO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced financial results for the third quarter ended September 30, 2024.
Third Quarter 2024 and... Read more
Q3 Reimbursements from insurance payors totaled $106,567 an increase of 16.4% sequentially
KindlyMD now provides more than 90% in-network insurance coverage in Utah SALT LAKE CITY, UT / ACCESSWIRE / November 13, 2024 / KindlyMD ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company redefining value-based care and patient-centered medical services, today announced its financial results for the third quarter ended September... Read more
HOUSTON / Nov 12, 2024 / Business Wire / U.S. Physical Therapy, Inc. (the “Company) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chief Executive Officer, will participate in the Stephens Annual Investment Conference on Wednesday, November 20, 2024. On the same day, Carey Hendrickson, Chief Financial Officer, will present at the 16th Annual Southwest IDEAS... Read more
Continued Profitable Growth
Vertical integration drives gross profit margin improvement
Launch of proprietary clinical decision support software to strengthen competitive advantages IRVING, Texas / Nov 12, 2024 / Business Wire / Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the third quarter ended September 30, 2024.
Third... Read more
BRENTWOOD, Tenn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the third quarter ended September 30, 2024. Revenues increased 14.3% to $770.4 million compared to the prior year period Same-facility revenues increased 4.2%
Same-facility cases increased 3.7% Net loss attributable to Surgery Partners,... Read more
LOUISVILLE, Ky. / Nov 12, 2024 / Business Wire / Leading health and well-being company Humana Inc. (NYSE: HUM) announced today that it has named Michelle O'Hara as Chief Human Resources Officer, effective January 1, 2025. O’Hara will oversee the enterprise talent strategy and people programs for Humana’s more than 63,000 employees. She brings a proven track record of transforming HR capabilities and enabling companies to effectively attract, recruit, develop and retain... Read more
Revenue increased 26% year-over-year to $362.1 million
Third quarter results were affected by lower risk adjustments, higher medical expenses in the current year, and retroactive adjustments
Executing key 2025 initiatives with a focus on improvements in profitability metrics
Management to Host Conference Call and Webcast November 12, 2024 at 4:30 PM ET HENDERSON, Nev. / Nov 12, 2024 / Business Wire / P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ:... Read more
ATLANTA / Nov 12, 2024 / Business Wire / SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $442,000 (or a loss of $0.06 per fully diluted share) for its first fiscal quarter ended September 30, 2024 compared to a loss from continuing operations of $428,000 (or a loss of $0.06 per fully diluted share) for the first fiscal quarter ended September 30, 2023. During the quarter ended September 30, 2024, the Company sold non-core... Read more
NASHVILLE, Tenn., Nov. 11, 2024 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") announced today that Lucinda "Cindy" Baier, President and Chief Executive Officer and Dawn Kussow, Executive Vice President & Chief Financial Officer will participate in the 2024 Stephens Annual Investment Conference on Wednesday, November 20, 2024.
The Brookdale fireside chat will begin at 8:00 am CST, and the live webcast can be accessed through... Read more
CERRITOS, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) announced that they have received certification to begin administering Pluvicto therapy in their outpatient California radiation oncology practices. Pluvicto, a radiopharmaceutical used to treat certain types of metastatic prostate cancer, has previously been administered primarily in hospital settings.
“We are ecstatic about the opportunity to offer... Read more
Turnaround continues to gain traction TAMPA, Fla., Nov. 11, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology platform company, which operates as a national Third-Party Administrator (TPA) through its subsidiaries and is transforming the $22 billion TPA market by offering affordable, intelligent, healthcare solutions to self-funded employer health plans, announced financial results for the third quarter of 2024. The... Read more
ALHAMBRA, Calif., Nov. 8, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it and its affiliated professional entities have entered into a definitive agreement to acquire Prospect Health ("Prospect"), which... Read more
Continued Expansion of Adjusted EBITDA and EBITDA Margin
TORONTO, Nov. 8, 2024 /CNW/ - CareRx Corporation ("CareRx" or the "Company") (TSX: CRRX), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today reported its financial results for the third quarter ended September 30, 2024.
"Over the past 18 months, we have been deeply committed to strengthening our business by modernizing our operating platform, reducing net... Read more
MURFREESBORO, Tenn. / Nov 08, 2024 / Business Wire / National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues and grant income for the quarter ended September 30, 2024 totaled $340,198,000 compared to $288,485,000 for the quarter ended September 30, 2023, an increase of 17.9%. The increase in net operating revenues for the third quarter of 2024 compared to the same period last... Read more
MIAMI BEACH, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the third quarter and nine months ended September 30, 2024.
“Our revenue and Adjusted EBITDA for the quarter were in line with our expectations with the period including progress on our strategy despite continued challenges in the consumer env... Read more
TOTAL REVENUE OF $222.3 MILLION FOR THE FIRST NINE MONTHS OF 2024 VS. $178.0 MILLION FOR THE SAME PERIOD IN 2023, AN INCREASE OF 25%
HOSPITAL DIVISION VISITS OF 122,944 FOR THE FIRST NINE MONTHS OF 2024 VS. VISITS OF 102,798 FOR THE SAME PERIOD IN 2023, AN INCREASE OF 20%
HOSPITAL DIVISION OPERATING INCOME OF $54.7 MILLION FOR THE FIRST NINE MONTHS OF 2024 VS. $21.1 MILLION FOR THE SAME PERIOD IN 2023, AN INCREASE OF 159%
NET CASH FROM OPERATING ACTIVITIES OF $23.1... Read more
HALIFAX, Nova Scotia, Nov. 07, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing home health care organization, is pleased to announce the release of financial results for the quarter ended September 30, 2024. All amounts are in United States dollars unless otherwise specified.
Nova Leap Q3 2024 Financial Results
Financial results for the third quarter ended September 30, 2024 include the following: Nova... Read more
Company to Host Conference Call on Thursday, November 7, 2024, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Nov. 7, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the... Read more
Company Significantly Expands Operations on the West Coast to Support New Payer Programs, Increases Full-Year Guidance for Cash Flow from Operations
Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time NEW YORK / Nov 07, 2024 / Business Wire / DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended September... Read more
Quarterly revenue of $688 million;
GAAP EPS of $0.18 and adjusted EPS of $0.61 DALLAS, Nov. 07, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2024 financial results. Financial highlights are as follows:
Dollars in millions, except per share amounts.
Q3 2024
% Change Q3 2023
YTD September... Read more
SCOTTSDALE, Ariz., Nov. 07, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, reported its financial results for the quarter ended September 30, 2024.
Financial Highlights: Q3 2024 Compared to Q3 2023 Grew revenue 2% to $30.2 million.
Reported net loss of $3.2 million, including $3.8 million in loss on disposition or impairment, compared to net loss of $716,000, including loss on disposition... Read more
Revenue increased 28% to $1.45 billion, Medicare Advantage membership increased 37% to 525,000, and total members on the agilon platform grew 39% to 657,000
Third quarter results were affected by lower-than-expected 2024 risk adjustment, negative prior year development mainly from risk adjustment and Part D, and higher current year medical expenses
Adjusted full year guidance reflects Q3 results and updated Q4 cost trends AUSTIN, Texas / Nov 07, 2024 / Business Wire... Read more
WELL surpassed $1 billion annualized revenue run-rate with record revenue of $251.7 million in Q3-2024, marking a 27%(1) increase compared to Q3-2023, mainly driven by organic growth of 23%.
WELL achieved record Adjusted EBITDA(2) of $32.7 million in Q3-2024, an increase of 16% as compared to Q3-2023.
WELL achieved a record total of 1.5 million total patient visits in Q3-2024 an increase of 41% compared to Q3-2023 and representing 5.9 million total patient visits on... Read more
TORONTO, Nov. 7, 2024 /CNW/ - Medical Facilities Corporation ("Medical Facilities," "MFC," or the "Corporation") (TSX: DR), reported its financial results today for the three-month and nine-month periods ended September 30, 2024. All amounts are expressed in U.S. dollars unless indicated otherwise.
Q3 2024 Highlights
(Compared to Q3 2023 and excluding the divested MFC Nueterra ambulatory surgery centers) Facility service revenue increased 0.2% to $103.6 million
Recognized... Read more
Third Quarter Revenue was $509.0 million, a 6.5% increase over the prior year period Gross margin increased 8.4% to $159.7 million, compared to Q3 2023 Third Quarter Net loss was $42.8 million, compared to net loss of $102.4 million in the comparable prior year period Adjusted Net income was $4.6 million, an increase of $9.3 million over the comparable prior year period Adjusted EBITDA was $47.8 million, a 32.2% increase as compared to the prior year... Read more
For the quarter ended September 30, 2024: Total Revenue of $2.4 billion, a 68% increase year-over-year
Medical Loss Ratio of 84.6%, an 80 bps increase year-over-year
SG&A Expense Ratio of 19.0%, a 360 bps improvement year-over-year
Net loss attributable to Oscar of $54.6 million, or $(0.22) of earnings per share, a $10.8 million improvement year-over-year
Adjusted EBITDA loss of $11.6 million, an $8.7 million improvement year-over-year NEW YORK /... Read more
SCOTTSDALE, Ariz., Nov. 07, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2024.
(All results compared to prior-year comparative period, unless otherwise noted)
Q3 2024 Highlights and FY 2024 Outlook Revenue of $312.7 million increased 19% compared to revenue of $262.9 million
Clinician base... Read more
PEMBROKE PINES, Fla., Nov. 7, 2024 /PRNewswire/ -- Sunshine Health, Florida's largest managed care organization and a Centene Corporation company (NYSE: CNC), announced today Charlene Zein has been named Plan President and Chief Executive Officer, effective Nov. 3, 2024. Zein has nearly two decades of experience in the healthcare industry, including various leadership roles of increasing scope and responsibility at Sunshine Health since joining in 2019. She... Read more
Delivered strongest financial performance to date in Q3 ‘24, resulting from continued positive momentum in NeueCare and NeueSolutions business segments
Drove positive Adjusted EBITDA for the third consecutive quarter in 2024; reaffirming Adjusted EBITDA guidance for the full year†
Well-positioned to build on success and capitalize on strategic growth opportunities in 2025 and beyond DORAL, Fla. / Nov 07, 2024 / Business Wire / NeueHealth, Inc. (“NeueHealth”... Read more
BRENTWOOD, Tenn. / Nov 06, 2024 / Business Wire / Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the third quarter ended September 30, 2024.
Third Quarter 2024 Operating and Financial Summary
All comparisons are versus the same prior year period, unless otherwise noted. See the footnotes to the Operating Statistics table... Read more
Company to host a conference call tomorrow, November 7, 2024, at 10 a.m. EST DALLAS / Nov 06, 2024 / Business Wire / Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2024.
“Our continued progress in our strategies during the third quarter resulted in Adjusted EBITDA growth year over year and strong free cash flow generation that led to further debt reduction,”... Read more
LOUISVILLE, Ky., Nov. 06, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud that CareMed, a BrightSpring company and leading independent Specialty Pharmacy, was selected by Eisai to be the national specialty pharmacy provider for Leqembi®, a cutting-edge treatment for Alzheimer’s disease.
“We’re proud of the work CareMed is doing with manufacturers and prescribers to improve and... Read more
BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024.
Three-Month Periods Ended September 30, 2024 and 2023 Net service revenue increased $31.5 million to $587.7 million compared to $556.2 million in 2023.
Net income attributable to Amedisys, Inc. of $16.9 million, which is inclusive of merger-related expenses totaling $16.7 million... Read more
NASHVILLE, Tenn., Nov. 6, 2024 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") announced results for the quarter ended September 30, 2024.
HIGHLIGHTS Third quarter consolidated weighted average occupancy grew 130 basis points over the prior year quarter and 80 basis points sequentially over the second quarter.
Same community operating income increased 10.1% over the prior year period, when excluding prior period... Read more
EAGLE, Idaho, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the third quarter of 2024, reporting GAAP diluted earnings per share of $0.20 for the third quarter of 2024. Pennant also reported adjusted diluted earnings per share of $0.26 for the quarter (1).
Third Quarter Highlights Total revenue... Read more
DENVER / Nov 06, 2024 / Business Wire / Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three and nine months ended September 30, 2024.
Third Quarter 2024 Summary: Service revenue of $702.0 million increased 2.2% from the third quarter of 2023 Net loss... Read more
Delivers 9% Total Revenue growth year-to-date compared to prior year period
Company improves 2024 year-to-date GAAP Net Loss from Continuing Operations by $117.4 million year-over-year and year-to-date Adjusted EBITDA by $87.2 million year-over-year
Increases Full-Year 2024 guidance midpoint to target updated range of Adjusted EBITDA profitability of $55 million - $65 million, strongly positioning the Company to invest in membership growth opportunity for... Read more
Financial Highlights Third quarter total revenues increased to $95.4 billion, up 6.3% compared to the prior year
Third quarter GAAP diluted EPS of $0.07 and Adjusted EPS of $1.09
Third quarter GAAP diluted EPS and Adjusted EPS include charges to record premium deficiency reserves of approximately $1.1 billion ($0.63 per share) in the Health Care Benefits segment
Generated year-to-date cash flow from operations of $7.2 billion CEO Commentary
"Our integrated model... Read more
Postpones Third Quarter 2024 Financial Results Conference Call FARMINGTON, Utah / Nov 06, 2024 / Business Wire / PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), today provided select preliminary key operating metrics for the third quarter and announced the postponement of the release of its third quarter 2024 financial results. PACS expects to release its third quarter 2024 financial results as soon as practicable.
“PACS Group operates in a highly... Read more
